Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19.
Braz J Psychiatry July 26, 2022 DOI: 10.47626/1516-4446-2022-2541 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractThe abstract proposes that ayahuasca, through its interaction with the sigma-1 receptor, may offer a potential treatment for COVID-19. It suggests that the sigma-1 receptor, which is targeted by certain components of ayahuasca, could play a role in mitigating the effects of the virus. The text does not present empirical data or results; it outlines a theoretical possibility based on known receptor interactions.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key finding | Proposes that ayahuasca's modulation of the sigma-1 receptor could offer a therapeutic approach for COVID-19 by affecting viral replication and inflammation. |
Abstract
Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19.